JP2019506866A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506866A5
JP2019506866A5 JP2018540841A JP2018540841A JP2019506866A5 JP 2019506866 A5 JP2019506866 A5 JP 2019506866A5 JP 2018540841 A JP2018540841 A JP 2018540841A JP 2018540841 A JP2018540841 A JP 2018540841A JP 2019506866 A5 JP2019506866 A5 JP 2019506866A5
Authority
JP
Japan
Prior art keywords
igg
polypeptide
protease activity
cysteine protease
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018540841A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019506866A (ja
JP7123801B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/052463 external-priority patent/WO2017134274A1/en
Publication of JP2019506866A publication Critical patent/JP2019506866A/ja
Publication of JP2019506866A5 publication Critical patent/JP2019506866A5/ja
Priority to JP2022056522A priority Critical patent/JP2022115853A/ja
Application granted granted Critical
Publication of JP7123801B2 publication Critical patent/JP7123801B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018540841A 2016-02-04 2017-02-03 新しい連鎖球菌プロテアーゼ Active JP7123801B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022056522A JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1630021-2 2016-02-04
SE1630021 2016-02-04
PCT/EP2017/052463 WO2017134274A1 (en) 2016-02-04 2017-02-03 New streptococcal proteases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022056522A Division JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Publications (3)

Publication Number Publication Date
JP2019506866A JP2019506866A (ja) 2019-03-14
JP2019506866A5 true JP2019506866A5 (enExample) 2020-03-12
JP7123801B2 JP7123801B2 (ja) 2022-08-23

Family

ID=57995190

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018540841A Active JP7123801B2 (ja) 2016-02-04 2017-02-03 新しい連鎖球菌プロテアーゼ
JP2022056522A Withdrawn JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022056522A Withdrawn JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Country Status (13)

Country Link
US (1) US12006530B2 (enExample)
EP (1) EP3411389B1 (enExample)
JP (2) JP7123801B2 (enExample)
KR (1) KR102704583B1 (enExample)
CN (1) CN109311951B (enExample)
AU (1) AU2017214441B2 (enExample)
CA (1) CA3013527C (enExample)
DK (1) DK3411389T3 (enExample)
ES (1) ES2877754T3 (enExample)
PL (1) PL3411389T3 (enExample)
PT (1) PT3411389T (enExample)
SG (1) SG11201806639VA (enExample)
WO (1) WO2017134274A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2944767C (en) 2014-04-04 2022-07-12 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
US11209439B2 (en) 2015-09-24 2021-12-28 Mayo Foundation For Medical Education And Research Identification of immunoglobulin free light chains by mass spectrometry
JP7123801B2 (ja) 2016-02-04 2022-08-23 ジェノビス エービー 新しい連鎖球菌プロテアーゼ
US10955420B2 (en) 2016-09-07 2021-03-23 Mayo Foundation For Medical Education And Research Identification and monitoring of cleaved immunoglobulins by molecular mass
CN111183221B (zh) 2017-05-26 2024-04-09 杰诺维斯公司 用于o-糖蛋白的蛋白酶和结合多肽
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
WO2019055632A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN CHAINS J
EP3681528B1 (en) 2017-09-13 2025-07-23 Mayo Foundation for Medical Education and Research Identification and monitoring of apoptosis inhibitor of macrophage
CN111447946A (zh) * 2017-12-15 2020-07-24 英特维特国际股份有限公司 用于针对猪链球菌进行保护的疫苗
WO2021067598A1 (en) 2019-10-04 2021-04-08 Ultragenyx Pharmaceutical Inc. Methods for improved therapeutic use of recombinant aav
BR112022015921A2 (pt) 2020-02-14 2022-10-04 Ultragenyx Pharmaceutical Inc Terapia gênica para tratar o transtorno de deficiência de cdkl5
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
JP2023532219A (ja) * 2020-06-18 2023-07-27 上海宝済薬業有限公司 免疫グロブリン分解酵素IdeEの突然変異体
IL301955A (en) 2020-10-07 2023-06-01 Asklepios Biopharmaceutical Inc Therapeutic delivery of an adeno-related protein-related protein (FKRP) virus for the treatment of dystroglycanopathy disorders, including limb girdle 21
CA3216491A1 (en) 2021-04-16 2022-10-20 Asklepios Biopharmaceutical, Inc. Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
US20240271115A1 (en) * 2021-06-15 2024-08-15 The University Of North Carolina At Chapel Hill Methods and compositions for depleting antibodies
WO2023019168A1 (en) 2021-08-11 2023-02-16 Ultragenyx Pharmaceutical Inc. Compositions and methods for treating a muscular dystrophy
CN118265540A (zh) * 2021-11-18 2024-06-28 英特维特国际股份有限公司 产生针对猪链球菌的疫苗的方法以及所述疫苗
TW202436348A (zh) * 2022-11-25 2024-09-16 日商中外製藥股份有限公司 蛋白質的製造方法
WO2025047641A1 (ja) * 2023-08-25 2025-03-06 積水メディカル株式会社 免疫学的測定方法、免疫学的測定用試薬、免疫学的測定用検体前処理液、及び免疫学的測定用試薬キット、非特異反応抑制剤
WO2025256978A1 (en) 2024-06-13 2025-12-18 Bayer Aktiengesellschaft Variants of igm and igg cleaving enzymes
WO2025256977A1 (en) 2024-06-13 2025-12-18 Bayer Aktiengesellschaft Novel igm and igg cleaving enzymes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
WO2006069200A2 (en) 2004-12-22 2006-06-29 Novartis Vaccines And Diagnostics Inc. Group b streptococcus
PT1901773E (pt) * 2005-06-09 2012-06-06 Hansa Medical Ab Utilização da proteinase ides (de s. pyogenes) para o tratamento de doenças e rejeição de enxertos
EP2190984B1 (en) 2007-09-14 2013-09-04 Genovis Ab Methods and kits for purification and detection of glycosylated IgG
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
JP7123801B2 (ja) 2016-02-04 2022-08-23 ジェノビス エービー 新しい連鎖球菌プロテアーゼ

Similar Documents

Publication Publication Date Title
JP2019506866A5 (enExample)
JP2014531205A5 (enExample)
Cid-Uribe et al. The diversity of venom components of the scorpion species Paravaejovis schwenkmeyeri (Scorpiones: Vaejovidae) revealed by transcriptome and proteome analyses
KR20130135028A (ko) 동물로부터 단일클론 항체의 고속 분리
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
RU2016129161A (ru) Усовершенствованный диагностический тест для csfv антител
FI20165814A7 (fi) Interleukiini 8 (il-8) prognostisena ja ennustavana biomarkkerina ja koostumukset ja vektorit käytettäväksi onkolyyttisessa immunoterapiassa
FI20165634A7 (fi) Laite ja menetelmät mikro-organismien identifioimiseksi häiritsevästä matriisista
AU2018274704A1 (en) Assay for plasma cell associated disease
Pastor-Fernandez et al. Characterization of the Neospora caninum NcROP40 and NcROP2Fam-1 rhoptry proteins during the tachyzoite lytic cycle
FI3630967T3 (fi) Proteaasi ja sitoutuva polypeptidi o-glykoproteiineja varten
JP2020522242A5 (enExample)
Ghodasara et al. Investigation of cattle plasma proteome in response to pain and inflammation using next generation proteomics technique, SWATH-MS
MX2018008809A (es) Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv.
HK1254818A1 (zh) 抗原肽及其用於诊断和治疗自闭症的用途
CN108276480A (zh) Pcv3抗原表位的多肽序列筛选方法
HK1258012A1 (zh) 新型蛋白质及检测方法
Schröder Discovery of natural bispecific antibodies: Is psoriasis induced by a toxigenic Corynebacterium simulans and maintained by CIDAMPs as autoantigens?
Matysiak et al. Association between venom immunotherapy and changes in serum protein—Peptide patterns
CN103336133A (zh) 一种用于检测抗mda5抗体的试剂盒及其检测方法
SG10201903424RA (en) ANTI HUMAN Gas6 MONOCLONAL ANTIBODY
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
Reed et al. Novel mass spectrometry based detection and identification of variants of rabies virus nucleoprotein in infected brain tissues
WO2013042917A3 (ko) 중공사막을 이용한 단백질의 효소 처리장치 및 이를 이용한 온-라인 프로테오믹스 방법